guidance

Johnson & Johnson Raises Forecast; Will Other Drug Companies Follow Suit?
Motley Fool
Thu, 04/19/12 - 11:48 am
JNJ
guidance
Forest Labs Earnings Call Nuggets: Guidance and New Product Catalysts
Wall St. Cheat Sheet
Thu, 04/19/12 - 11:47 am
earnings
guidance
Forest Labs
Forest Labs FY13 guidance likely to below consensus, says Goldman
The Fly on the Wall
Fri, 04/13/12 - 09:55 am
guidance
Forest Labs
Illumina Predicts 1Q Sales Will Trump Street
FOX Business
Mon, 04/2/12 - 12:15 pm
Illumina
guidance
Roche
Merck Warns First-Quarter Earnings Below Estimates
CNBC
Tue, 03/6/12 - 11:01 am
Merck
guidance
Novartis' Rasilez to Carry Warning Novartis' Rasilez to Carry Warning
Yahoo/AP
Wed, 02/22/12 - 05:38 pm
Mylan
guidance
Actelion Sees 2012 Profit Unchanged as Economic Crisis Hurts Drug Prices
Bloomberg
Tue, 02/14/12 - 11:04 am
guidance
Actelion
AstraZeneca Declines Most in 5 Months on Forecast: London Mover
Bloomberg
Fri, 02/3/12 - 09:58 am
guidance
AstraZeneca
AstraZeneca to cut 7,300 jobs, post lower profit
Marketwatch
Thu, 02/2/12 - 09:13 am
layoffs
AstraZeneca
guidance
Roche Sees 2012 Profit Growth on New Drugs
Bloomberg
Wed, 02/1/12 - 09:04 am
Roche
guidance
Warner Chilcott expects 2012 revenue to fall on bone-drug volume declines in the US
Yahoo/AP
Fri, 01/27/12 - 10:22 am
Warner Chilcott
guidance
There have been red faces at AstraZeneca after the company sent confidential information to analysts by mistake
InPharm
Mon, 01/9/12 - 10:15 am
guidance
AstraZeneca
AstraZeneca reaffirms EPS guidance for 2011
Marketwatch
Mon, 01/9/12 - 09:51 am
AstraZeneca
guidance
Ista Pharma expects greater income, sales in 2012
Yahoo/AP
Thu, 01/5/12 - 12:25 pm
Ista
guidance
Lilly’s 2012 Forecast Misses Analysts’ Estimates
Bloomberg
Thu, 01/5/12 - 10:04 am
Eli Lilly
guidance
Drugmaker Eli Lilly to detail 2012 earnings, revenue forecast Thursday
Yahoo/AP
Wed, 01/4/12 - 12:04 pm
guidance
Eli Lilly
Dendreon 2011: Supply Constrained to Missed Guidance
Motley Fool
Fri, 12/16/11 - 11:31 am
Dendreon
guidance
Provenge
prostate cancer
P&G raises profit outlook on Teva JV, Pringles sale
Yahoo/AP
Thu, 11/3/11 - 12:19 pm
Teva Pharmaceuticals
P&G
guidance
Actelion Plunges After Forecasting Declining Sales in 2012
Bloomberg
Thu, 10/20/11 - 09:23 am
guidance
earnings
Actelion
Illumina expects 3Q revenue of $235 million, suspends 2011 outlook as weakness to continue
Yahoo/AP
Fri, 10/7/11 - 10:51 am
Illumina
guidance

Pages